Weekly insulin vs daily insulins for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new once-weekly insulin shot (icodec) compared to daily long-acting insulins for people with type 2 diabetes whose blood sugar is not well controlled on their current non-insulin medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for at least 6 months.
- You are currently taking at least one non-insulin diabetes medication (like metformin, a GLP-1 drug, or others).
- Your doctor has decided you need to add a long-acting insulin to help control your blood sugar.
- Your average blood sugar (HbA1c) level was 7% or higher in the last 3 months.
- You are not pregnant, breastfeeding, or planning to become pregnant (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
This study looks at how well once-weekly insulin icodec controls blood sugar and improves quality of life for people with type 2 diabetes who currently take daily insulin injections. You'll switch from your daily insulin to a once-weekly injection and the study will track your blood sugar control, treatment satisfaction, and how well you stick with the new schedule.
This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.
This study tests a new once-weekly insulin (icodec) against a standard daily insulin (glargine), both taken with mealtime insulin. It aims to see which works better to control blood sugar in adults with type 1 diabetes.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This trial tests different ways to start a new long-acting insulin called icodec for people with type 2 diabetes. It looks at how to give an extra dose on day 4 to help control blood sugar better.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.